Why Do Some CGT Companies Make It and Others End Up as Slide Decks?
It’s not just the tech. It’s not just the team. It’s knowing why you’re building in CGT and how to survive the regulatory gauntlet, investor mood swings, and the reality of manufacturing what you promised.
This conference isn’t about big claims and vague visions. It’s for the people in the trenches the ones raising Series A with 18 months of runway and 6 months of data, the ones explaining viral vectors to board members who still think DNA is proprietary.
We’re gathering the founders, therapy developers, and strategic minds behind the CGT companies that actually get built. If that’s you, or who you’re trying to become, save the date. You’ll want to be in the room.
Who should join?
This event is built for people shaping CGT companies from the inside out.
- Founders making hard calls on funding and focus.
- Commercial leads figuring out how to position what’s still in development.
- Regulatory and CMC leads translating ambition into approvals.
- Investors who know the next big thing won’t look like the last one.
If you’re building, backing, or scaling in CGT —you belong here.
The Program — Designed for Execution
Besides keynote talks from CGT veterans who’ve built, led, and scaled programs across development stages, the program runs in parallel streams focused on clinical strategy, regulatory progress, and CMC readiness. Each session will offer hands-on insight into planning, coordination, and decision-making.
Alongside the main program, you’ll find a curated carousel of emerging enabling technologies, expert-led workshops on critical topics, and dedicated space for 1:1 partnering conversations grounded in real expertise.
It’s a working agenda for teams actively building the next generation of CGT companies.
Source: https://futureofcgt.com